|
|
Volumn 110, Issue 6, 2004, Pages
|
|
Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ATORVASTATIN;
CLOPIDOGREL;
CYP3A PROTEIN, HUMAN;
CYTOCHROME P450;
DRUG DERIVATIVE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRROLE DERIVATIVE;
TICLOPIDINE;
CARDIOVASCULAR DISEASE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INTERACTION;
HUMAN;
METABOLISM;
MORTALITY;
NOTE;
SAMPLE SIZE;
THROMBOCYTE AGGREGATION;
CARDIOVASCULAR DISEASES;
CYTOCHROME P-450 ENZYME SYSTEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PYRROLES;
SAMPLE SIZE;
TICLOPIDINE;
MLCS;
MLOWN;
|
|
EID: 16644401883
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.0000137956.92971.4a Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
